Race as a Factor in Donor Selection and Survival of Children
with Hematologic Malignancies Undergoing Hematopoietic Stem Cell
Transplant in Florida
Biljana Horn, MD1, Nikhil Lamba,
BS1, Deepak Chellapandian, MDMD
MBBS2 Gauri Sunkersett, DO2, Jorge
Galvez Silva, MD3, Edward Ziga, MD4,
Warren Alperstein, MD4, Michael Joyce, MD,
PhD5, Paul Castillo, MD1, John Fort,
MD1, Jing Zhao, PhD, MS.1 and
Benjamin Oshrine, MD2
Affiliations:
(1) University of Florida, Gainesville, FL
(2) Center for Cell and Gene Therapy for Non Malignant-Conditions, Blood
and Marrow Transplant Program, Cancer & Blood Disorders Institute,
Johns Hopkins All Children’s Hospital, St Petersburg, FL; (3) Nicklaus
Children’s Hospital, Miami, FL
(4) Pediatric Hematology and Oncology, University of Miami School of
Medicine, Miami, FL (5) Nemours Children’s Clinic and Wolfson Children’s
Hospital, Jacksonville, FL
Corresponding Author:
Biljana Horn, e-mail: Biljana.horn@ufl.edu
1600 SW Archer Avenue, Gainesville, FL 32610
Phone (mobile) 415-215-6930, FAX: 352 294 8091
Article Type: Research Article
Word Count: abstract 249
Word Count: main text 2152
Tables: 2, Figures: 2, References: 17
Short Title: Race and outcomes in children undergoing HCT
Key Words: race disparities, pediatric HCT, malignant disorders, Florida
consortium
Abbreviations used in the manuscript: